Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann F Chambers

Showing results (81-90 of 133) with videos related to

Pageof 14
Sort By:
Investigative Radiology|June 27, 2008
Contrast-enhanced microcomputed tomography using intraperitoneal contrast injection for the assessment of tumor-burden in liver metastasis modelsKevin C Graham, Sarah A Detombe, Lisa T MacKenzie, et al.
Comptes Rendus Biologies|January 28, 2004
Osteopontin identified as colon cancer tumor progression markerDeepak Agrawal, Tingan Chen, Rosalyn Irby, et al.
Scientific Reports|September 11, 2014
Stage of breast cancer progression influences cellular response to activation of the WNT/planar cell polarity pathwayConnor D MacMillan, Hon S Leong, David W Dales, et al.
Journal of Magnetic Resonance Imaging : JMRI|June 24, 2011
In vivo single scan detection of both iron-labeled cells and breast cancer metastases in the mouse brain using balanced steady-state free precession imaging at 1.5 TEmeline J Ribot, Francisco M Martinez-Santiesteban, Carmen Simedrea, et al.
Breast Disease|May 3, 2007
Brain metastases of breast cancerDiane Palmieri, Quentin R Smith, Paul R Lockman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2003
Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesisDaria Leali, Patrizia Dell'Era, Helena Stabile, et al.
Investigative Radiology|July 27, 2011
In vivo characterization of changing blood-tumor barrier permeability in a mouse model of breast cancer metastasis: a complementary magnetic resonance imaging approachDean B Percy, Emeline J Ribot, Yuhua Chen, et al.
Scientific Reports|January 24, 2015
CORRIGENDUM: Stage of Breast Cancer Progression Influences Cellular Response to Activation of the WNT/Planar Cell Polarity PathwayConnor D MacMillan, Hon S Leong, David W Dales, et al.
Clinical & Experimental Metastasis|June 11, 2008
BRMS1 suppresses breast cancer metastasis in multiple experimental models of metastasis by reducing solitary cell survival and inhibiting growth initiationBenjamin D Hedley, Kedar S Vaidya, Pushar Phadke, et al.
Breast Cancer Research and Treatment|January 2, 2004
Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastasesGeorge N Naumov, Jason L Townson, Ian C MacDonald, et al.
Pageof 14

Showing results (81-90 of 133) with videos related to

Sort By:
Pageof 14
Investigative Radiology|June 27, 2008
Contrast-enhanced microcomputed tomography using intraperitoneal contrast injection for the assessment of tumor-burden in liver metastasis modelsKevin C Graham, Sarah A Detombe, Lisa T MacKenzie, et al.
Comptes Rendus Biologies|January 28, 2004
Osteopontin identified as colon cancer tumor progression markerDeepak Agrawal, Tingan Chen, Rosalyn Irby, et al.
Scientific Reports|September 11, 2014
Stage of breast cancer progression influences cellular response to activation of the WNT/planar cell polarity pathwayConnor D MacMillan, Hon S Leong, David W Dales, et al.
Journal of Magnetic Resonance Imaging : JMRI|June 24, 2011
In vivo single scan detection of both iron-labeled cells and breast cancer metastases in the mouse brain using balanced steady-state free precession imaging at 1.5 TEmeline J Ribot, Francisco M Martinez-Santiesteban, Carmen Simedrea, et al.
Breast Disease|May 3, 2007
Brain metastases of breast cancerDiane Palmieri, Quentin R Smith, Paul R Lockman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2003
Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesisDaria Leali, Patrizia Dell'Era, Helena Stabile, et al.
Investigative Radiology|July 27, 2011
In vivo characterization of changing blood-tumor barrier permeability in a mouse model of breast cancer metastasis: a complementary magnetic resonance imaging approachDean B Percy, Emeline J Ribot, Yuhua Chen, et al.
Scientific Reports|January 24, 2015
CORRIGENDUM: Stage of Breast Cancer Progression Influences Cellular Response to Activation of the WNT/Planar Cell Polarity PathwayConnor D MacMillan, Hon S Leong, David W Dales, et al.
Clinical & Experimental Metastasis|June 11, 2008
BRMS1 suppresses breast cancer metastasis in multiple experimental models of metastasis by reducing solitary cell survival and inhibiting growth initiationBenjamin D Hedley, Kedar S Vaidya, Pushar Phadke, et al.
Breast Cancer Research and Treatment|January 2, 2004
Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastasesGeorge N Naumov, Jason L Townson, Ian C MacDonald, et al.
Pageof 14